SUVENPHAR.NS Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 12:00):

Stats
Tagesvolumen	122 136
Durchschnittsvolumen	507 623
Marktkapitalisierung	167.94B
EPS	INR0 ( 2024-02-05 )
Nächstes Ertragsdatum	( INR0 ) 2024-05-22
Last Dividend	INR5.00 ( 2022-09-09 )
Next Dividend	INR0 ( N/A )
P/E	45.25
ATR14	INR0.616 (0.09%)

Volumen Korrelation

Lang: -0.44 (neutral)

Kurz: 0.59 (weak)

Signal:(22.642) Neutral

Suven Pharmaceuticals Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Suven Pharmaceuticals Korrelation - Währung/Rohstoff

-0.26
( neutral )

-0.14
( neutral )

0.46
( neutral )

-0.18
( neutral )

0.30
( neutral )

-0.35
( neutral )

Suven Pharmaceuticals Finanzdaten

Annual	2022
Umsatz:	INR13.40B
Bruttogewinn:	INR7.55B (56.32 %)
EPS:	INR16.16

FY	2022
Umsatz:	INR13.40B
Bruttogewinn:	INR7.55B (56.32 %)
EPS:	INR16.16

FY	2022
Umsatz:	INR12.90B
Bruttogewinn:	INR7.35B (56.96 %)
EPS:	INR17.83

FY	2021
Umsatz:	INR9.80B
Bruttogewinn:	INR5.60B (57.12 %)
EPS:	INR14.23

Financial Reports:

No articles found.

Suven Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR5.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Suven Pharmaceuticals Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 2.51 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.000	2021-02-17
Last Dividend	INR5.00	2022-09-09
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	5	--
Total Paid Out	INR10.00	--
Avg. Dividend % Per Year	0.37%	--
Score	3.37	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	2.51
Div. Directional Score	7.25	--

Next Divdend (Est)
(2024-07-22)

INR0 Estimate 0.00 %

Dividend Stability

0.11 Bad

Dividend Score

3.37

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2021	INR2.00	0.43%
2022	INR8.00	1.62%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
RAMAPHO.NS	No Dividend Player	2023-08-10	Annually	3	0.17%
KKCL.NS	Dividend Knight	2023-05-11	Semi-Annually	19	1.67%
ENIL.NS	Dividend Junior	2023-09-15	Annually	12	0.39%
ALICON.NS	Dividend Junior	2023-09-13	Annually	18	0.25%
SUTLEJTEX.NS	Dividend Junior	2023-08-18	Annually	18	1.03%
NDRAUTO.NS	Dividend Junior	2023-07-12	Annually	4	0.59%
ICICIGI.NS	Dividend Junior	2023-06-12	Annually	8	0.36%
CENTENKA.NS	Dividend Junior	2023-08-11	Annually	22	1.85%
RUBYMILLS.NS	Dividend Junior	2023-09-20	Annually	23	0.96%
LINCOLN.NS	Dividend Junior	2023-09-15	Annually	9	0.32%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.318	1.500	3.65	5.47	[0 - 0.5]
returnOnAssetsTTM	0.180	1.200	3.99	4.79	[0 - 0.3]
returnOnEquityTTM	0.201	1.500	8.88	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	26.98	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	20.95	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	17.94	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0168	-1.500	9.72	-10.00	[0 - 0.6]
interestCoverageTTM	94.82	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	3.86	2.00	8.71	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.86	2.00	8.07	10.00	[0 - 20]
debtEquityRatioTTM	0.0174	-1.500	9.93	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.587	1.000	3.55	3.55	[0.2 - 0.8]
operatingProfitMarginTTM	0.424	1.000	3.51	3.51	[0.1 - 0.6]
cashFlowToDebtRatioTTM	2.85	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.567	0.800	9.55	7.64	[0.5 - 2]
Total Score				12.00

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	45.28	1.000	5.53	0	[1 - 100]
returnOnEquityTTM	0.201	2.50	9.28	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.86	2.00	8.71	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.86	2.00	8.71	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-4.83	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0842	1.000	-0.396	0	[0.1 - 0.5]
Total Score				2.51

Suven Pharmaceuticals

Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was incorporated in 2018 and is headquartered in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.